Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Area of Science:

• Psychopharmacology
• Mental Health Research

Background:

• Psychedelic microdosing involves sub-perceptual doses of classic psychedelics.
• Anecdotal evidence suggests mood and well-being benefits, but controlled studies lack robust findings.
• Recent placebo-controlled trials have not provided compelling evidence for efficacy.

Purpose of the Study:

• To investigate the effects of a weekly psychedelic microdosing regimen on mental health and well-being.
• To examine the role of participant expectations in the outcomes of psychedelic microdosing.
• To provide a prospective evaluation of psychedelic microdosing over a four-week period.

Main Methods:

• A prospective, web-based study design was employed.
• Participants (N=81) planning weekly microdosing completed surveys before, during, and after a four-week period.
• Data collected included measures of psychological well-being, emotional stability, anxiety, depression, resilience, and social connectedness.

Main Results:

• Significant improvements were reported in psychological well-being, emotional stability, and reductions in anxiety and depressive symptoms.
• Increases in psychological resilience, social connectedness, agreeableness, nature relatedness, and psychological flexibility were observed.
• Baseline positive expectancy scores strongly predicted subsequent improvements in well-being, indicating a substantial placebo response.

Conclusions:

• Positive expectancy plays a crucial role in the perceived benefits of psychedelic microdosing.
• The study cautions against overstating the therapeutic value of psychedelic microdosing due to the significant placebo effect.
• Further research is needed to disentangle the specific effects of psychedelics from expectancy effects in microdosing protocols.